Group A streptococcal infections facts
What is group A Streptococcus (GAS)?
Group A Streptococcus is defined as a gram-positive bacterial genus composed of Streptococcus pyogenes strains. Group A Streptococcus strains have a similar surface antigen recognized by Lancefield serogrouping tests, termed the Lancefield group A antigen. Lancefield groups (there are about 18 Lancefield groups) are composed of different Streptococcus species groups that have specific antigens and are distinguished by specific Lancefield antibody tests. In addition, group A Streptococcus strains are beta hemolytic (beta hemolytic means the bacteria lyse red blood cells suspended in agar plates with secreted substances, see for example, Fig. 3). These tests are mentioned because they are frequently used to distinguish group A Streptococcus bacteria from group B, group C, and other Streptococcus groups. Group A Streptococcus bacteria appear as pairs and chains when gram-stained (see Fig. 1); these bacteria are also termed "beta strep, GAS, and GABHS." Although these bacteria can harmlessly colonize people on their throat and skin, sometimes they can cause mild to serious diseases. GAS bacteria have been causing diseases in humans probably since humans first developed.
Streptococcus pyogenes (GAS) bacteria have many components that contribute to the pathogen's ability to cause disease:
Exotoxins cause the scarlet fever rash, damage organs, may cause shock, and inhibit the human immune system, while the human immune system stimulators may stimulate the immune system to produce antibodies that likely play a role in the development of autoimmune responses that can lead to glomerulonephritis or acute rheumatic fever. S. pyogenes (GAS) has over 100 serotypes that may vary somewhat in their ability to produce the above components that contribute to the pathogenicity of each strain of the bacteria.
Figure 1: Photo of Streptococcus pyogenes (GAS). SOURCE: CDCHow are group A streptococcal (GAS) infections contracted?
In most instances, GAS bacteria are contracted from other people by direct contact with mucus, skin, or infected lesions. Spread of the GAS organisms occurs infrequently by items that have made contact with infected people. However, many people are colonized (have the bacteria on body surfaces but are not infected) with GAS bacteria. Infants and children often first acquire these organisms from their colonized mothers.
What diseases are caused by group A streptococcal infection?
There are a number of diseases that GAS organisms can cause. The predominant diseases are as follows:
This list is not exhaustive as GAS bacteria have been found in many other disease processes. In addition, many of the diseases listed above may also be caused by many other pathogens, although the first three listed (pharyngitis, scarlet fever, and rheumatic fever) are predominantly caused by GAS. Some investigators consider most of these diseases as complications of an initial GAS skin or throat infection.
What are the symptoms and signs of GAS infections?
GAS infections can produce many different signs and symptoms:
Most of the diseases listed here for GAS infection usually occur after an initial pharyngitis, with necrotizing fasciitis and toxic shock sometimes occurring without a detectable initial pharyngitis infection. Other disease processes involving GAS organisms (for example, meningitis, bone infections, pneumonia, wound infections, and others) produce the typical symptoms associated with these disease processes and clinically are not unique for GAS or other pathogenic organisms.
Figure 2: Picture of a Streptococcus pyogenes (Strep throat) infection. SOURCE: CDC/Dr. Heinz F. EichenwaldWhat is invasive group A streptococcal disease? Who is most at risk for getting invasive GAS disease?
Invasive GAS disease is when GAS organisms invade and infect organs or organ systems in the body (for example, GAS infections of the blood, muscle, fatty tissue, or the lungs). These are serious infections, and the mortality rate (death rate) varies from about 10%-60%, depending on the area(s) of the body infected. The most severe forms of invasive GAS infections are with necrotizing fasciitis and streptococcal toxic shock syndrome described below. People at higher risk for getting invasive forms of GAS are individuals with chronic diseases and immunosuppressed patients (for example, cancer, diabetes, and renal failure patients, and people taking steroid-type medications). Most healthy people do not get this type of GAS disease, but if they have skin breaks (cuts, abrasions, recent surgical sites), these individuals have a higher risk of GAS disease than people without skin breaks.
Other patients who are at risk for invasive GAS disease are patients with GAS infections that can easily progress into deep fat and muscle (for example, a GAS infection near the scrotum or anus or an abscess in the skin) and can progress to necrotizing fasciitis. Toxic shock syndrome was initially found to be associated with vaginal infections secondary to tampon use (or inappropriate use such as leaving a tampon in the vagina for an extended time). However, any patient who has a wound or surgery that requires packing to reduce bleeding (for example, nasal packing for severe nose bleeding) is at increased risk for toxic shock syndrome. Toxic shock syndrome may also be caused by a different bacterium called Staphylococcus.
Consequently, risk factors for GAS organisms to cause infection include suppression of the immune system (see above), open wounds or wound packing, or tampons that may promote GAS survival and proliferation. Children and the elderly are at higher risk to become infected with GAS.
What are the symptoms and signs of necrotizing fasciitis?
Early signs and symptoms of necrotizing fasciitis include fever, severe pain, swelling, and erythema (redness) at the wound site or site where GAS organisms entered the body. The pain and swelling may extend well beyond the erythema. Skin changes may resemble cellulitis initially, but ulceration, scabs, and fluid draining from the site develop, sometimes rapidly (Fig. 3). GAS organisms then can spread to the bloodstream and the patient can develop bacteremia and septic shock with high fever and a low blood pressure. About 20% of patients with necrotizing fasciitis caused by GAS will die from the infection.
Figure 3: Picture of necrotizing fasciitis (flesh-eating disease)What are the signs and symptoms of toxic shock syndrome (TSS)?
Early symptoms of TSS are nonspecific and often begin with flu-like symptoms of mild fever and malaise. However, TSS often suddenly advances with symptoms of high fever, nausea, vomiting, diarrhea, skin rash, and a low blood pressure. If it progresses, confusion, headaches, seizures, and skin loss from the palms of the hands and from the soles of the feet can occur. The blood pressure can become dangerously low so that body organs are not profused with enough blood, and if multiorgan failure develops, the patient often dies. The death rate varies widely, depending on how well the patient can respond to treatment. GAS bacteria and Staphylococcus aureus are the predominant bacteria that cause TSS.
How are group A streptococcal (GAS) infections diagnosed?
After a history and physical examination, many clinicians presumptively diagnose strep throat from its symptom production and throat appearance (see Fig. 2). However, cultures from the throat or other site of infection form the basis of definitive testing. For example, GAS organisms will grow on sheep blood agar plates that contain two different antibiotics and cause beta hemolysis (complete sheep blood red cell lysis to form a clear area) of the sheep red blood cells (see Fig. 3). In addition, there are rapid tests (RADT or rapid antigen detection test) that take only a few minutes to complete that detect a carbohydrate surface antigen produced by GAS, with specificity of about 95% or better and fairly good sensitivity of about 80%-90%.
Because there are many other groups of Streptococcus spp., positive identification of the infecting bacteria is necessary to separate out other bacteria that may cause some similar symptoms but may require a different workup, different treatment, and produce different complications.
Figure 3: Image of beta hemolysis. SOURCE: CDC/Richard R. Facklam, PhDThese tests help distinguish GAS from Streptococcus pneumoniae and other organisms.
What is the treatment for invasive group A streptococcal disease?
Antibiotics treat invasive GAS infections as well as noninvasive GAS infections. Although many antibiotics may be adequate treatment for GAS infections, the best practice methods would be to determine antibiotic sensitivity of GAS bacteria to be sure the bacteria are susceptible to the antibiotics. Milder infections caused by GAS (strep throat, skin infections) are often treated with oral antibiotics (for example, penicillin v [Pen-Vee-K, Veetids], amoxicillin [Amoxil, Dispermox, Trimox], cephalosporins; if allergic to penicillins, erythromycin [E-Mycin, Eryc, Ery-Tab, Pce, Pediazole, Ilosone], azithromycin [Zithromax, Zmax]). Some third-generation cephalosporins (for example, ceftriaxone [Rocephin]), given IV or IM, followed by oral antibiotics are useful to treat mild to moderate infections. However, invasive GAS infections require a more aggressive treatment approach. High doses of penicillin, together with clindamycin (Cleocin) by sequential IV administration, are often recommended. Some investigators suggest adding immune globulin to the multi-antibiotic treatment.
In addition to antibiotics, surgical intervention may be necessary to remove dead and dying tissue to limit the spread of invasive GAS organisms. This is almost always done in patients who develop necrotizing fasciitis. In addition, early diagnosis and treatment of invasive GAS infections yield the best patient outcomes. Many clinicians consult with an infectious-disease specialist to help determine the best antibiotic therapy for individual patients. More GAS strains are being reported to have some resistance to one or more antibiotics so the treatment may require alterations in antibiotics. The infectious-disease specialist can help choose the most effective antibiotic combinations to treat antibiotic-resistant GAS organisms.
Learn more about: Eryc | Ery-Tab | Pce | Pediazole | Zithromax | Zmax | ceftriaxone | Rocephin
What complications are seen with group A streptococcal infections?
Many of the complications of GAS infections are considered to be diseases themselves. For example, scarlet fever, rheumatic fever, necrotizing fasciitis, toxic shock syndrome, and many others can complicate or be triggered by GAS infection. Other complications can include the necessity to remove tonsils, renal damage, abscess formation, seizures, and other organ damage; some researchers suggest that severe GAS infections in children may lead to permanent or long-lasting brain changes.
Can group A streptococcal infections be prevented?
Many GAS infections can be prevented by reducing the spread of organisms from one person to another. Washing hands frequently is one of the major ways to reduce bacterial transmission. In addition, not sharing the same food and drink containers with others may also be effective. For those people with a GAS infection, covering the mouth and nose when sneezing or coughing can reduce the chance of transmitting the bacteria to others. Washing material that comes in contact with GAS-infected people is also another way to reduce exposure to GAS organisms.
Early treatment of deep infections (for example, excision, drainage, and antibiotic treatment of rectal abscesses) helps prevent invasive GAS disease. In addition, appropriate and timely removal of tampons and surgical packing may reduce the incidence of toxic shock syndrome.
Currently, there is no vaccine commercially available for GAS, but researchers are working on developing vaccines. At least four different major approaches are being researched. There has been some success with a related experimental vaccine against GAS bacterial antigens coupled to cholera toxin subunits. However, the GAS vaccine, prepared by recombinant technology by Vaxent, a vaccine company, may be going into human clinical trials. The new experimental vaccines may become available in the future to prevent GAS infections.
What is group A Streptococcus (GAS)?
Group A Streptococcus is defined as a gram-positive bacterial genus composed of Streptococcus pyogenes strains. Group A Streptococcus strains have a similar surface antigen recognized by Lancefield serogrouping tests, termed the Lancefield group A antigen. Lancefield groups (there are about 18 Lancefield groups) are composed of different Streptococcus species groups that have specific antigens and are distinguished by specific Lancefield antibody tests. In addition, group A Streptococcus strains are beta hemolytic (beta hemolytic means the bacteria lyse red blood cells suspended in agar plates with secreted substances, see for example, Fig. 3). These tests are mentioned because they are frequently used to distinguish group A Streptococcus bacteria from group B, group C, and other Streptococcus groups. Group A Streptococcus bacteria appear as pairs and chains when gram-stained (see Fig. 1); these bacteria are also termed "beta strep, GAS, and GABHS." Although these bacteria can harmlessly colonize people on their throat and skin, sometimes they can cause mild to serious diseases. GAS bacteria have been causing diseases in humans probably since humans first developed.
Streptococcus pyogenes (GAS) bacteria have many components that contribute to the pathogen's ability to cause disease:
Exotoxins cause the scarlet fever rash, damage organs, may cause shock, and inhibit the human immune system, while the human immune system stimulators may stimulate the immune system to produce antibodies that likely play a role in the development of autoimmune responses that can lead to glomerulonephritis or acute rheumatic fever. S. pyogenes (GAS) has over 100 serotypes that may vary somewhat in their ability to produce the above components that contribute to the pathogenicity of each strain of the bacteria.
Figure 1: Photo of Streptococcus pyogenes (GAS). SOURCE: CDCHow are group A streptococcal (GAS) infections contracted?
In most instances, GAS bacteria are contracted from other people by direct contact with mucus, skin, or infected lesions. Spread of the GAS organisms occurs infrequently by items that have made contact with infected people. However, many people are colonized (have the bacteria on body surfaces but are not infected) with GAS bacteria. Infants and children often first acquire these organisms from their colonized mothers.
What diseases are caused by group A streptococcal infection?
There are a number of diseases that GAS organisms can cause. The predominant diseases are as follows:
This list is not exhaustive as GAS bacteria have been found in many other disease processes. In addition, many of the diseases listed above may also be caused by many other pathogens, although the first three listed (pharyngitis, scarlet fever, and rheumatic fever) are predominantly caused by GAS. Some investigators consider most of these diseases as complications of an initial GAS skin or throat infection.
What are the symptoms and signs of GAS infections?
GAS infections can produce many different signs and symptoms:
Most of the diseases listed here for GAS infection usually occur after an initial pharyngitis, with necrotizing fasciitis and toxic shock sometimes occurring without a detectable initial pharyngitis infection. Other disease processes involving GAS organisms (for example, meningitis, bone infections, pneumonia, wound infections, and others) produce the typical symptoms associated with these disease processes and clinically are not unique for GAS or other pathogenic organisms.
Figure 2: Picture of a Streptococcus pyogenes (Strep throat) infection. SOURCE: CDC/Dr. Heinz F. EichenwaldWhat is invasive group A streptococcal disease? Who is most at risk for getting invasive GAS disease?
Invasive GAS disease is when GAS organisms invade and infect organs or organ systems in the body (for example, GAS infections of the blood, muscle, fatty tissue, or the lungs). These are serious infections, and the mortality rate (death rate) varies from about 10%-60%, depending on the area(s) of the body infected. The most severe forms of invasive GAS infections are with necrotizing fasciitis and streptococcal toxic shock syndrome described below. People at higher risk for getting invasive forms of GAS are individuals with chronic diseases and immunosuppressed patients (for example, cancer, diabetes, and renal failure patients, and people taking steroid-type medications). Most healthy people do not get this type of GAS disease, but if they have skin breaks (cuts, abrasions, recent surgical sites), these individuals have a higher risk of GAS disease than people without skin breaks.
Other patients who are at risk for invasive GAS disease are patients with GAS infections that can easily progress into deep fat and muscle (for example, a GAS infection near the scrotum or anus or an abscess in the skin) and can progress to necrotizing fasciitis. Toxic shock syndrome was initially found to be associated with vaginal infections secondary to tampon use (or inappropriate use such as leaving a tampon in the vagina for an extended time). However, any patient who has a wound or surgery that requires packing to reduce bleeding (for example, nasal packing for severe nose bleeding) is at increased risk for toxic shock syndrome. Toxic shock syndrome may also be caused by a different bacterium called Staphylococcus.
Consequently, risk factors for GAS organisms to cause infection include suppression of the immune system (see above), open wounds or wound packing, or tampons that may promote GAS survival and proliferation. Children and the elderly are at higher risk to become infected with GAS.
What are the symptoms and signs of necrotizing fasciitis?
Early signs and symptoms of necrotizing fasciitis include fever, severe pain, swelling, and erythema (redness) at the wound site or site where GAS organisms entered the body. The pain and swelling may extend well beyond the erythema. Skin changes may resemble cellulitis initially, but ulceration, scabs, and fluid draining from the site develop, sometimes rapidly (Fig. 3). GAS organisms then can spread to the bloodstream and the patient can develop bacteremia and septic shock with high fever and a low blood pressure. About 20% of patients with necrotizing fasciitis caused by GAS will die from the infection.
Figure 3: Picture of necrotizing fasciitis (flesh-eating disease)What are the signs and symptoms of toxic shock syndrome (TSS)?
Early symptoms of TSS are nonspecific and often begin with flu-like symptoms of mild fever and malaise. However, TSS often suddenly advances with symptoms of high fever, nausea, vomiting, diarrhea, skin rash, and a low blood pressure. If it progresses, confusion, headaches, seizures, and skin loss from the palms of the hands and from the soles of the feet can occur. The blood pressure can become dangerously low so that body organs are not profused with enough blood, and if multiorgan failure develops, the patient often dies. The death rate varies widely, depending on how well the patient can respond to treatment. GAS bacteria and Staphylococcus aureus are the predominant bacteria that cause TSS.
What complications are seen with group A streptococcal infections?
Many of the complications of GAS infections are considered to be diseases themselves. For example, scarlet fever, rheumatic fever, necrotizing fasciitis, toxic shock syndrome, and many others can complicate or be triggered by GAS infection. Other complications can include the necessity to remove tonsils, renal damage, abscess formation, seizures, and other organ damage; some researchers suggest that severe GAS infections in children may lead to permanent or long-lasting brain changes.
Can group A streptococcal infections be prevented?
Many GAS infections can be prevented by reducing the spread of organisms from one person to another. Washing hands frequently is one of the major ways to reduce bacterial transmission. In addition, not sharing the same food and drink containers with others may also be effective. For those people with a GAS infection, covering the mouth and nose when sneezing or coughing can reduce the chance of transmitting the bacteria to others. Washing material that comes in contact with GAS-infected people is also another way to reduce exposure to GAS organisms.
Early treatment of deep infections (for example, excision, drainage, and antibiotic treatment of rectal abscesses) helps prevent invasive GAS disease. In addition, appropriate and timely removal of tampons and surgical packing may reduce the incidence of toxic shock syndrome.
Currently, there is no vaccine commercially available for GAS, but researchers are working on developing vaccines. At least four different major approaches are being researched. There has been some success with a related experimental vaccine against GAS bacterial antigens coupled to cholera toxin subunits. However, the GAS vaccine, prepared by recombinant technology by Vaxent, a vaccine company, may be going into human clinical trials. The new experimental vaccines may become available in the future to prevent GAS infections.
Source: http://www.rxlist.com
Other patients who are at risk for invasive GAS disease are patients with GAS infections that can easily progress into deep fat and muscle (for example, a GAS infection near the scrotum or anus or an abscess in the skin) and can progress to necrotizing fasciitis. Toxic shock syndrome was initially found to be associated with vaginal infections secondary to tampon use (or inappropriate use such as leaving a tampon in the vagina for an extended time). However, any patient who has a wound or surgery that requires packing to reduce bleeding (for example, nasal packing for severe nose bleeding) is at increased risk for toxic shock syndrome. Toxic shock syndrome may also be caused by a different bacterium called Staphylococcus.
Consequently, risk factors for GAS organisms to cause infection include suppression of the immune system (see above), open wounds or wound packing, or tampons that may promote GAS survival and proliferation. Children and the elderly are at higher risk to become infected with GAS.
Source: http://www.rxlist.com
We respect your privacy and aim for the best website experience in compliance with local laws. Allowing cookies enables a tailored experience, while disabling them may reduce personalization. For more information, please read our Privacy Policy and Cookie Policy.